PREVIEW
Although diabetes clearly increases the risk for cardiovascular disease, secondary prevention often is overlooked in diabetic patients. Clinical trials show that aggressive lipid-lowering therapy provides significant benefit in diabetic patients with coronary artery disease, often to an even greater extent than in the non-diabetic population. In this article, Dr Bohannan looks at a number of secondary prevention strategies for patients with diabetes and discusses when and why to use them.